Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study
Archives of Dermatological Research · 2024
DOI: 10.1007/s00403-024-02939-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Bayoumy Ibrahim Eassa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Hussein University Hospital, Al-Azhar University, Box 32515, Al-Darasah…. Hauptthemen laut MEDLINE: Polidocanol, Sclerotherapy, Warts, Injections, Intralesional. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Hussein University Hospital, Al-Azhar University, Box 32515, Al-Darasah, Cairo, Egypt.
- Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Hussein University Hospital, Al-Azhar University, Box 32515, Al-Darasah, Cairo, Egypt. dr_akamel@hotmail.com.
ORCID-Profile: Ahmad Kamel Seddeik Abdel-Hameed
Zitieren
APA
Eassa, B. I., Abdel-Hameed, A. K. S., & Ismail, A. I. A. (2024). Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-02939-9
Vancouver
Eassa BI, Abdel-Hameed AKS, Ismail AIA. Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-02939-9
BibTeX
@article{Eassa2024,
author = {Eassa, Bayoumy Ibrahim and Abdel-Hameed, Ahmad Kamel Seddeik and Ismail, Ahmed Ismail Ali},
title = {Safety and efficacy of intralesional polidocanol sclerotherapy in the treatment of plantar warts: a pilot study},
journal = {Archives of Dermatological Research},
year = {2024},
doi = {10.1007/s00403-024-02939-9}
}
EUVIMED